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ABSTRACT. The efficiency of maghemite nanoparticles for the treatment of anemia was 
sensibly higher when nanoparticles were incorporated onto the probiotic bacterium 
Lactobacillus fermentum (MNP-bacteria) than when administrated as uncoated nanoparticles 
(MNP). Plasma iron and hemoglobin, intestine expression of divalent metal transporter 1 
(DMT1) and duodenal cytochrome B (DcytB), as well as hepatic expression of the hormone 
hepcidin were fully restored to healthy levels after administration of MNP-bacteria but not of 
MNP. A magnetic study on biodistribution and biodegradation showed accumulation of 
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maghemite nanoparticles in intestine lumen when MNP-bacteria were administrated. In 
contrast, MNP barely reached intestine. 
In vivo MRI studies suggested the internalization of MNP-bacteria into enterocytes, which did 
not occur with MNP. Transmission electronic microscopy confirmed this internalization.  
The collective analysis of results point out that L. fermentum is an excellent carrier to 
overcome the stomach medium and drive maghemite nanoparticles to intestine, where iron 
absorption occurs. Due the probiotic ability to adhere to the gut wall, MNP-bacteria 
internalize into the enterocyte, where maghemite nanoparticles are delivered, providing an 
adequate iron level into enterocyte. This paper advances a new route for effective iron 
absorption in the treatment of anemia. 
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INTRODUCTION  
Iron deficiency, the most common cause of anemia, is the nutritional disorder of greatest 
impact in the world.1 As well as affecting a large number of children and women in 
developing countries, it is the only prevailing nutrient deficiency in industrialized countries.2-6 
Iron has vital functions such as to carry O2 from the lungs to tissues, to transfer electrons for a 
great variety of redox reactions or to carry out enzymatic oxidative reactions.7 Iron deficiency 
provokes therefore interferences with these vital functions and leads to morbidity and death.8  
Although the importance of iron absorption in health has been recognized for decades, the 
mechanism by which the body regulates this process remains unclear. What is clear is that if 
loss of iron is not sufficiently compensated by adequate iron intake from the diet or 
supplements, an iron deficiency anemia occurs.9  
To increase daily iron intake, numerous supplements based on different iron chemicals have 
been developed and some of them are commercially available.10-12 It is well known the main 
side effect of these iron supplements: gastrointestinal discomfort.13 Ferrous sulfate for 
instance, the most commonly used iron supplement due to its low cost, may cause stomach 
pain and nausea.14,15 Likewise, supplements based on iron salts and complexes can suffer 
from hydrolysis going through stomach, and the delivered iron has low bioavailability and in 
addition, is inhibited by a variety of components of the diet.10-12,17  
Iron oxide nanoparticles have emerged as promising iron supplements since they can be more 
bioactive than classical chemical forms and have better access to enter tissues.18-22 However, 
some works showed that large uncoated iron oxide nanoparticle aggregate under physiological 
conditions and produce serious toxicological effects.23-25 Therefore, it is necessary to consider 
the toxicological hazards of iron nanoparticles and establish the parameters (surface properties, 
charge, size, shape, and the engineered surface functionalization of the nanoparticles) that 
optimize their efficiency as iron supplements without side effects.  
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The use of an appropriate coating is essential to overcome the stomach medium and carry the 
iron nanoparticles to intestine, where iron absorption takes place.9,26 We have recently 
reported that probiotic bacteria, Lactobacillus fermentum and Bifidobacteria breve, serve as 
platforms to densely arrange small iron oxide nanoparticles on their external surfaces.27-29 
These are promising materials for iron supplements since, first we have found that the bacteria 
remain alive after grafting nanoparticles, and secondly because probiotic bacteria constitute 
part of natural microbiota and are able to survive the stomach conditions and nest in different 
sites of the gastrointestinal tract.  
The aim of the present study was to investigate small maghemite nanoparticles (average size 
10 nm), uncoated (MNP) or incorporated on L. fermentum (MNP-bacteria) as new iron 
supplements for iron deficiency in anemic rats. No adverse symptoms or mortality of anemic 
rats were observed after 23 days of oral administration of MNP or MNP-bacteria. However, 
the efficiency of these materials in alleviating anemia was sensibly higher when incorporated 
onto the probiotics (MNP-bacteria) than when isolated (MNP).  
A full set of experiments, including magnetic analysis of the different rat tissues after 
administration of MNP and MBP-bacteria, in vitro MRI and electronic microscopy studies on 
HT-29 human cell line after treatment with MNP and MNP-bacteria pointed out that bacteria 
with nanoparticles (MNP-bacteria) are internalized by enterocytes, which advances a new 
route to ensure iron absorption. Restoration of healthy levels of blood parameters and iron-
related protein expressions after administration of MNP-bacteria to anemic rats confirmed the 
efficiency of this material as a new drug for anemia. 
 
RESULTS AND DISCUSSION  
Thirty rats were rendered anemic by feeding them with an iron-deficient diet. Then, they were 
randomly divided into five groups: an untreated anemic group, and anemic groups treated 
with L. fermentum, iron sulfate, MNP or MNP-bacteria at the same iron dose. A control group 
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of six healthy (non-anemic) rats was also included in the study (Scheme 1). The different 
types of iron supplements were given to rats once a day by intragastric administration for 23 
days. Observation of food intake and body weight revealed no adverse signs, symptoms, or 
mortality after the 23 days of treatment. 
 
 
Scheme 1. Animals Treatment. Rats were randomly divided into six groups: a control group 
(healthy, non-anemic), an untreated anemic group, and four anemic groups treated with: L. 
fermentum, iron sulfate, MNP or MNP-bacteria. The last three groups at the same iron dose.  
 
Magnetic study of luminal contents from tissues. Since iron absorption takes place at 
specific sites of the gastrointestinal tract, mainly in intestine,9,26 we focused to analyze the 
presence of maghemite nanoparticles in the lumen of different sections of the gastrointestinal 
tract after administration of MNP or MNP-bacteria. Magnetic measurements of lyophilized 
lumen from small intestine, cecum and colon were performed. In particular, we studied the 
temperature dependence of the magnetic ac susceptibilities, both the in-phase (χ’) and out-
phase (χ″) components of these three samples for every treatment with MNP or MNP-bacteria 
(Figure 1). The study of the temperature dependence of the ac susceptibility is a highly 
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sensitive technique for the detection of superparamagnetic iron oxide nanoparticles in 
biological tissues as well as for monitoring their partial or full degradation processes.30-32 
 
Figure 1. Temperature dependence of the ac magnetic susceptibility, both the in-phase (χ’) 
and out-phase (χ″) components of lumen samples from different sections of the 
gastrointestinal tract: cecum (pink), colon (violet) and small intestine (blue).  
 
The in- and out-phase susceptibilities of samples from the treatment with MNP-bacteria 
exhibited maxima in all the tissues, which is indicative of the presence of superparamagnetic 
particles. In contrast, the magnetic behavior corresponding to the luminal contents of the 
different tissues after administration of MNP did not exhibit any maxima, which informs of 
the absence of maghemite nanoparticles. In addition, a paramagnetic low temperature 
contribution in the in-phase susceptibility was clearly observed. This contribution corresponds 
to the presence of iron cations resulting from the degradation of maghemite nanoparticles.  
From these data it can be concluded that the incorporation of the maghemite nanoparticles 
onto the probiotic (MNP-bacteria) allow nanoparticles overcoming the stomach medium and 
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reaching the intestine. In contrast, MNP undergoes biodegradation, probably at the stomach, 
which makes negligible the amount of maghemite nanoparticles accumulated in the intestinal 
lumen.  
Plasma iron and hemoglobin levels. Anemia is characterized by a decrease of iron and 
hemoglobin (Hb) levels in blood. As it can be seen in Figure 2, due to the iron-deficient diet, 
plasma iron and Hb levels of anemic rats were lower (p < 0.05) than those of healthy rats 
(controls). The group that was supplemented with MNP showed a slight increase in plasma 
iron and practically no significant difference in Hb level when compared with the anemic 
group (p > 0.05). In contrast, the administration of MNP-bacteria restored the physiological 
plasma iron and Hb levels as occurred with the administration of iron sulfate, the most 
common iron supplement. 
 
Figure 2. Plasma iron and Hb values in the six rat groups: healthy, iron-deficient and treated 
with (from left to right) L. fermentum, ferrous sulfate, MNP and MPN-bacteria. Error bars, 
±sem (n=6). Different letters show statistically significant differences (p < 0.05). 
 
Expressions of biomolecules of iron homeostasis. Figure 3 shows the results of DMT1 and 
DcytB protein gene expression analysis in the small intestine from the different groups of rats. 
A proper functioning of this tandem of proteins is essential for iron absorption. Iron enters the 
small intestine mainly as Fe(III) as the result of Fe(II) oxidation by gastric juice components. 
The ferrireductase protein DcytB is highly expressed at duodenal enterocytes and reduces 
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Fe(III) to Fe(II). Upon reduction, Fe(II) is transferred across the apical membrane of 
enterocytes by divalent metal transporters, mainly DMT1. Accordingly to these functions, the 
expressions of DcytB and DMT1 dramatically increase in periods of high body iron demand, 
as occurs during anemia. Figure 3 shows that in fact, the expression of DcytB and DMT1 
increased in anemic rats with respect to those of the control (healthy rats). The administration 
of MNP-bacteria leads to a restoration of healthy levels of both proteins, pointing out that the 
supplementation of iron is effective. However, the administration of iron sulfate or MNP does 
not move the DcytB and DMT1 levels until those of healthy rats. This suggests that the 
administration of iron sulfate or MNP at this dose in these conditions is not efficient to 
decrease the iron demand caused by anemia. Interestingly, the effect of the administration of 
MNP-bacteria on DcytB is similar to that of bacteria without iron. As recently reported, some 
compounds excreted by L. fermentum have ferrireductase activity,33 making functions of 
DcytB and therefore, the expression of DcytB does not increase in rats administrated with L. 
fermentum. 
 
 
Figure 3. DMT1 and DcytB mRNA expression in small intestine tissue of: healthy, iron-
deficient and treated rats with (from left to right): L. fermentum, ferrous sulfate, MNP and 
MPN-bacteria. Error bars, ±sem (n=6). Different letters show statistically significant 
differences (p < 0.05). 
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On the other hand, once inside the enterocytes, Fe(II) is transported to plasma by the 
membrane protein ferroportin, the activity of which is regulated by the hormone 
hepcidin.34 This hormone is expressed in the liver and is up-regulated when hepatic 
iron stores are high and down-regulated when iron stores are decreased. Because liver 
iron levels are representative of the store regulator for iron absorption, hepcidin 
expression inversely correlates with the amount of iron absorbed by the intestine. 
Likewise, the decrease of hepcidin correlates with an increase in the duodenal 
expression of DcytB and DMT1. 
Figure 4 shows how in fact, the expression of hepcidin decreases in anemic rats. However, 
after administration of MNP-bacteria, iron sulfate and, to a lesser extend MPN, the hepcidin 
expression levels increases with respect to that of anemic rats, reaching values corresponding 
to those of healthy rats. 
 
Figure 4. Hepcidin mRNA expression in liver of healthy, iron-deficient and treated rats with 
(from left to right): L. fermentum, ferrous sulfate, MNP and MPN-bacteria. Error bars, ±sem 
(n=6). Different letters show statistically significant differences (p < 0.05). 
 
After magnetic study on biodistribution it is clear that MNP-bacteria allow 
accumulating maghemite nanoparticles at sites where iron absorption takes place. After 
the collective analysis of blood parameters and mRNA expressions of DcytB, DMT1 
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and hepcidin reveals that MNP-bacteria is more effective for treatment of anemia since 
it restores the healthy blood parameters. This means that the accumulation of 
maghemite nanoparticles at intestine seems an ideal scenario to ensure appropriate iron 
absorption. However, no information from these data can be infered about the 
mechanism by which the presence of MNP-bacteria at intestine does ensure the enter 
of iron into blood to remediate anemia. With the aim to explore this mechanism we 
performed an in vitro MRI experiment and a transmission electron microscopy (TEM) 
study to evaluate the internalization of maghemite nanoparticles into HT-29 human 
cells after incubation with MNP or MNP-bacteria.  
Internalization of maghemite nanoparticles into enterocyte cells. We compared the 
internalization level of maghemite nanoparticles into enterocytes by measuring the 
transversal relaxation times (T2) of water protons when incubated the cells with MNP 
or MNP-bacteria. After incubation for 30 min, the wells were exhaustively washed 
with water to remove any material not internalized in cells. 
 
 
Figure 5. T2-weighted MR images after incubation of enterocyte cells (line HT-29) 
with a) L. fermentum; b) MNP; c) untreated well and d) MNP-bacteria. The negative 
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contrast informs of the accumulation of magnetic material into cells. 1/T2 values are 
represented in e. 
 
As it is evident from Figure 5, the incubation with MNP-bacteria resulted in a strong 
effect on the signal intensity of the T2-weighted MR images. In contrast, MNP 
produced a negligible effect, with T2 values close to those of controls, without 
magnetic material (Figure 5). These results evidence the internalization of maghemite 
nanoparticles into enterocytes only in the case of MNP-bacteria, which points out some 
role of the probiotic to promote internalization.  
TEM images of HT-29 cells treated with MNP-bacteria showed unequivocally the 
presence of MNP-bacteria and maghemite nanoparticles, localized intracellularly in 
endosomal/lysosomal compartments (Figure 6). No internalization of maghemite 
nanoparticles was observed when the cells were treated with MNP. These data make 
clear that the mechanism of the internalization of maghemite nanoparticles into 
enterocyte takes place by the internalization of nanoparticles-containing bacteria 
(MNP-bacteria), which are clearly observed in Figure 6. The presence of maghemite 
nanoparticles would be therefore consequence of the degradation of MNP-bacteria 
inside the endosome. Once delivered, these nanoparticles form the large aggregated 
found in Figure 6.  
In this sense, it is interesting to note that some previous works reported by Juillerat-
Jeanneret et al.35 concluded that cationic magnetite nanoparticles, of the same size than 
those used in the present work, internalized in HT-29 cells. This apparent contradiction 
is explained in terms of the existence of a polyvinylamine coating around the magnetite 
nanoparticles whereas we used uncoated maghemite nanoparticles.  
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Figure 6. a) A typical TEM micrograph of thin epoxy resin sections of cell line HT-29 
incubated with MNP-bacteria showing large accumulation of nanoparticles (black 
arrow) and MNP-bacteria (white arrow) at endosomal/lysosomal compartments of one 
HT-29 cell (m is the mitochondria and n the nucleus). b) EDX compositional maps of 
iron collected over the whole image in (a).  
 
The collective analysis confirms the crucial role of the nanoparticle coating for internalization 
into enterocyte. In the present work we have used a living transporter, the probiotic bacterium 
L. fermentum. The present study demonstrates that maghemite nanoparticles grafted onto this 
probiotic bacterium (MNP-bacteria) has positive effects upon anemic rats sensibly better than 
uncoated nanoparticles (MNP) and the standard supplement iron sulfate. These results note 
the role of the probiotic as an efficient oral carrier of maghemite nanoparticles, since it allows 
overcoming the chemical medium of stomach, driving the nanoparticle to intestine, where 
maghemite nanoparticles internalize into enterocytes and ensure the restoration of blood 
parameters and alleviate anemia.  
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METHODS  
Maghemite nanoparticles synthesis. MNP were synthesized according to Massart’s method 
by co-precipitation of Fe(II) and Fe(III) salts in a stoichiometry of 0.5.36 By adjusting the pH 
to 11 with 3M NaOH and ionic strength with 1M NaNO3, the average size of the resulting 
magnetite nanoparticles is 10 nm. After oxidation of magnetite to maghemite with 1M HClO4, 
a colloid of maghemite nanoparticles stable at pH 2 was obtained. 
Grafting maghemite nanoparticles to bacteria. For the preparation of MNP–bacteria, a 
liquid culture of probiotic Lactobacillus fermentum CECT5716 was grown in a common 
bacterial growth medium such as MRS at 37 °C with orbital agitation for 24 h. Bacteria were 
centrifuged at 3000g for 5 min and washed with distilled water. Then, an acid solution (pH 2) 
of MNP (66.6 µL, 0.95 M) was added to the bacteria in an ice bath and mixed. The solution 
was diluted to 1 mL with distilled water. Bacteria labeled with maghemite nanoparticles 
(MNP–bacteria) were collected at 100g, 20 min. 
MNP and MNP–bacteria characterization was carried out by Transmission Electron 
Microscopy (TEM) as previously reported.27 
Animals. This study was carried out in accordance with the ‘Guide for the Care and 
Use of Laboratory Animals’ as promulgated by the National Institute of Health. All 
studies involving animals are reported in accordance with the ARRIVE guidelines for 
reporting experiments involving animals.37,38 
Male Wistar rats (180–200 g) obtained from Janvier (St Berthevin Cedex, France) were 
housed individually in Makrolon cages, maintained in an air-conditioned atmosphere 
with a 12 h light–dark cycle, and provided with free access to tap water and food ad 
libitum. They were randomly assigned to two different experimental groups. One of 
them received only the standard diet, whereas the other was fed an iron deficient diet 
(TD.80396) provided by Harlan Laboratories (Madison, WI, USA). Blood from tail 
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veins were collected and tests for Fe content were carried out weekly until the fourth 
week. In this moment, IDA was established and the group fed iron deficient diet was 
subdivided into 5 groups. Three groups received a supplement of iron (1 mg per day 
per animal) by: iron sulfate solution, suspension of MNP or suspension of MNP–
bacteria respectively. The two remaining groups were: a not treated anemic group; and 
an anemic group treated with L. fermentum. All the groups were treated for 23 days 
(Scheme 1). All the treatments were daily administered by oral gavage. Food and 
water intake was daily recorded for all groups (n=6). Rat body weight was measured 
twice a week. No significant differences were observed in animal weight among the 
groups throughout the experiment. 
Biological samples. Blood samples were taken weekly from the hepatic portal vein in 
a heparinized tube to analyze the blood panel. After 23 days of treatment, the rats were 
sacrificed and the different parts of gastrointestinal tract and liver were collected and 
weighed. To obtain the luminal content of the different tissues of the gastrointestinal 
tract; small intestine, cecum and colon were emptied of their luminal material. 
Intestinal, colonic and cecal lumen were separately frozen in liquid nitrogen and 
freeze-dried and stored at −80 °C. Finally, lyophilized lumen of the tissue samples was 
pulverized and the corresponding powders were analyzed for their magnetic 
characterization. 
Magnetic characterization. Lumen of the different tissues of the gastrointestinal tract 
from the groups treated with MNP–bacteria and MNP, separated by group and tissue, 
were freeze-dried and the corresponding powders were placed in gelatine capsules for 
magnetic characterization. Measurements were performed in a Quantum Design 
MPMS-XL SQUID magnetometer equipped with an AC (alternating current) magnetic 
susceptibility option. AC susceptibility measurements were performed with an AC 
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amplitude of 0.41 Oe, in the temperature range between 10 and 300 K and at a 
frequency of 11 Hz.  
Gene expression analysis. The expression of DMT1 and DcytB markers was 
determined in small intestine, the hepcidin expression was determined in liver. Total 
RNA from the small intestine and liver samples was isolated using TRI Reagent®, 
according to the manufacturer’s instructions. Purity and RNA concentration were 
measured by the absorbance ratio at 260 and 280 in a Thermo Scientific Nano Drop 
TM 2000 Spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). RNA (2 
µg) was reverse transcribed using oligo(dT) primers (Promega, Southampton, UK). 
Subsequently, 20 ng of complementary DNA was taken for real-time quantitative PCR 
amplification and detection, which was accomplished on optical-grade 48-well plates 
in an Eco™ Real-Time PCR System (Illumina, San Diego, CA, USA) with the KAPA 
SYBR® FAST qPCR Master Mix (Kapa Biosystems, Inc., Wilmington, MA, USA) 
and  specific primers for each gene (GAPDH: FW: CCATCACCATCTTCCAGGAG, 
RV: CCTGCTTCACCACCTTCTTG; hepcidin: 
FW:CACAGCAGAACAGAAGGCATG, RV: CTTCTGCTGTAAATGCTGT; 
DMT1: FW: GTGTTGGATCCTGAAGAAAAGATTCC, RV: 
GGGATTTTCTCATCAAAGTAGGTGGT; DCytB: FW: 
AGTGCAGCAAGTTCTTGATGAAAT, RV: CGTGGCAATCACTGTTCCAA).The 
expression of the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) was measured to normalize messenger RNA (mRNA) expression. The 
mRNA relative quantitation was calculated with the ∆∆Ct method and expressed as 
fold-change compared with the non-colitic control. 
Statistics. Statistical analysis was performed using SPSS version 20.0 software (SPSS, 
Inc.) and GraphPad Prism version 6.0 (GraphPad Software Inc., La Jolla, CA, United 
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States), and data were expressed as mean ± SEM. Differences between more than two 
groups were assessed using one-way ANOVA followed by Tukey’s test. Significant 
differences were established at P ≤ 0.05. 
In vitro internalization in enterocyte cells. HT-29 epithelial human colorectal 
adenocarcinoma cells were provided by the Scientific Instrumentation Centre 
(University of Granada, Spain). Cell line was grown adherently and maintained in 
McCoy's 5a medium + 2 mM glutamine + 1 mM of sodium pyruvate + 10% of fetal 
bovine serum (FBS) at 37 °C in 5% CO2. All experiments were performed in 12-well 
plates. Cells were seeded onto the plates at a density of 5×104 cells per well and 
incubated for 48 h prior to the experiments.  
In vitro T2 measurement by MRI. For MRI experiments HT-29 cells were treated 
separately with: MNP-bacteria (0.94 mM of Fe), MNP (0.94 mM of Fe) and L. 
fermentum. Wells were filled up to a final volume of 2 ml with the grown medium. A 
blank sample containing only cells was also prepared. The plate was incubated at 37 °C 
for 30 min. After incubation wells were washed three times with PBS 6.8 solution. 
Finally cells were trypsinized and transferred to a suitable plate for MRI measurement. 
Transversal relaxation times, T2, were measured on a 9.4T Bruker Biospec system 
using a 128-echo CPMG (Carl-Purcell-Meiboom-Gill) imaging sequence and the 
following acquisition parameters: TE values from 7.5 ms to 960 ms, TR= 3000 ms, 
FOV = 6 cm, matrix size = 256x256, slice thickness = 1 mm. T2 values were 
calculated using automated scripts written in IDL (Interactive Data Language, 
Research Systems Inc., Boulder, USA). 
In vitro internalization of MNP-bacteria study by Electronic Microscopy. After 
the same treatment as in MRI experiment, HT-29 cells were embedded in epoxy resine. 
Fixation was performed by adding glutaraldehyde 2.5% in 0.1 M sodium cacodilate 
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buffer at 4 °C for 4 h. The sample was washed 3 times in 0.1 M sodium cacodilate 
buffer for 15 min. 0.1% Osmium tretroxide in 0.1 M sodium cacodilate buffer was 
added and let stand for 1 h. Osmium tretroxide was washed three times with 0.1 M 
sodium cacodilate buffer for 15 min every time. Then, dehydration took place through 
a series of ethanol and propylene oxide. Finally, the sample was embedded in epoxy 
resin and left overnight at 4 °C. After ultramicro-cutting, samples were observed with a 
FEI TITAN G2 microscope. 
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Probiotic bacteria containing iron oxide nanoparticles is an advanced material for the 
treatment of anemia. The new approach is based on the use of probiotic bacteria as 
transporter of iron oxide nanoparticles from stomach to inside the enterocyte 
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